AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $494K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$494K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $25.47
- 52-wk high
- $33.06
- High
- $25.96
- 52-wk low
- $16.10
- Low
- $25.40
- Prev close
- $25.44
- Mkt cap
- $1.90B
- P/E
- 26.9x
- Volume
- 1.08M
- Fwd P/E
- 11.8x
- Beta
- 0.99
- P/S
- 1.5x
- P/B
- 4.4x
- Profit margin
- +6.0%
- Op margin
- +11.4%
- ROE
- +16.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PGNY filings
Are insiders buying or selling Progyny Inc (PGNY) stock?
Net selling: insiders sold $494K and bought $0 of PGNY stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $173K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Gordon, Kevin K (Director), who sold $321K. The latest filing was on Sep 28, 2026.
Which members of Congress have traded PGNY recently?
None. No member of Congress disclosed a PGNY trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PGNY smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- CI
Citadel
$51.5M
bought
- LA
LSV Asset
$25.5M
added
- BG
Baillie Gifford
$31.1M
bought
What insiders are doing
How top traders are positioned
No tracked top-trader positions in PGNY right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 21.4% above what analysts expected.
Earnings per share
$0.28 expected
Reports Nov 5, 2026, in 35 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $313.3M | $318.4M | $328.5M | $350.5M |
| Cost of what it sold | $240.5M | $241.5M | $245.4M | $261.2M |
| Gross profit | $72.8M | $76.9M | $83.1M | $89.3M |
| What it spent | ||||
| Sales and admin | $32.3M | $44.8M | $30.8M | $31.2M |
| Other operating costs | $19.0M | $16.9M | $16.9M | $18.1M |
| Total operating expenses | $51.3M | $61.7M | $47.7M | $49.3M |
| What was left | ||||
| Operating profit | $21.5M | $15.2M | $35.4M | $40.0M |
| Profit before tax | $24.0M | $17.9M | $36.9M | $41.1M |
| Tax | $10.1M | $5.4M | $12.7M | $13.1M |
| Net profit | $13.9M | $12.5M | $24.2M | $28.1M |
| EBITDA | $25.2M | $19.2M | $38.4M | $44.2M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
20 macro signals shaping PGNY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results